Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

CzechiaBack to Czechia

Clinical trials in Benatky nad Jizerou

2 clinical trials in Benatky nad Jizerou, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Benatky nad Jizerou at a glance
2
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Benatky nad Jizerou

Open in trial search

Arteriosclerosis

Recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB

Dyslipidaemia

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Benatky nad Jizerou

What the registry says about research in the country

01 Benatky nad Jizerou
Cardiovascular Diseases
The clinical trial activity in Benatky nad Jizerou focuses on cardiovascular diseases, especially studies designed for people at high risk of serious heart and vascular events. Researchers are evaluating whether new lipid-lowering therapy approaches can better protect patients from major cardiovascular complications. Adults at high risk of cardiovascular events without prior myocardial infarction or stroke Atherosclerotic cardiovascular disease Testing treatments aimed at reducing major heart, stroke, and vascular outcomes Comparing investigational care with placebo to assess preventive benefit These studies are centered on improving long-term cardiovascular risk reduction for patients who have not yet had a major event.
Nutritional and Metabolic Diseases
Another key research area involves nutritional and metabolic diseases, with a strong overlap in cholesterol management and vascular risk control. The trials are examining whether newer therapies can support better outcomes for people already receiving optimized lipid-lowering treatment. High-risk patients receiving optimized lipid-lowering therapy Preventing coronary heart disease death and related events Studying the impact on ischemic stroke and arterial revascularization Evaluating treatment effectiveness versus placebo This research reflects a preventive approach, aiming to lower the chance of future cardiovascular complications through improved metabolic control.
Back to CzechiaAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.